Paternal HBV infection prior to pregnancy may be associated with increased CHD risk in offspring, according to results of a large matched cohort study.

The Infectious Diseases Society of America (IDSA) 2024 guidance on the treatment of AMR gram-negative infections has been published.

Patients with inflammatory bowel disease (IBD), especially women, have a high prevalence of sexual dysfunction (SD), according to a study in the Journal of Crohn’s and Colitis. The findings are from a ...

A new prognostic model can predict and stratify hepatocellular carcinoma risk in noncirrhotic adult patients with chronic hepatitis B.

Habitual coffee or caffeine intake is associated with a lower risk for new-onset cardiometabolic multimorbidity.

Use of ultra-short-acting β-blockers (esmolol or landiolol) for persistent tachycardia in patients with sepsis may not reduce mortality.

In patients with chronic liver disease, including PBC, ursodeoxycholic acid shows promise as an adjunctive therapy for COVID-19 infection.

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The US Vaccines for Children program has prevented millions of cases of illness, hospitalizations, and deaths, resulting in massive direct and societal savings.

COVID-19 has no impact on BMI trajectory or lung function in people with cystic fibrosis in the year following infection.

HIV PrEP medications are usually prescribed by PCPs; however, adherence to PrEP varies by clinician specialty due to the different populations served.